Literature DB >> 27458060

Randomized clinical trial: benefits of aerobic physical activity for 24 weeks in postmenopausal women with nonalcoholic fatty liver disease.

Rosamar E F Rezende1, Sebastião M B Duarte, Jose T Stefano, Hamilton Roschel, Bruno Gualano, Ana L de Sá Pinto, Denise C P Vezozzo, Flair J Carrilho, Claudia P Oliveira.   

Abstract

OBJECTIVE: The aim of the study was to evaluate the effectiveness of aerobic physical activity in reducing the frequency of hepatic steatosis and metabolic and cardiovascular risk in postmenopausal women with nonalcoholic fatty liver disease (NAFLD).
METHODS: Forty sedentary postmenopausal women (mean age 55.3 ± 8.0 y) with biopsy-proven NAFLD were randomly divided into two groups: an exercising group (19 participants) and a control group (nonexercising, 21 participants). The exercise group underwent a supervised aerobic physical activity program of 120 min/wk for 24 weeks. The anthropometric parameters; body composition; hepatic, lipid, and glycemic profiles; homeostasis model assessment of insulin resistance index; cytokines; transient elastography (FibroScan; liver stiffness/controlled attenuation parameter); and cardiopulmonary exercise test were evaluated at baseline and after 24 weeks of protocol.
RESULTS: At baseline there were no significant differences in anthropometric, metabolic, and inflammatory parameters-stiffness and liver fat content by FibroScan between the groups. After 24 weeks, we observed a decrease of waist circumference, an increase of high-density lipoprotein cholesterol levels (P < 0.05), and improved cardiopulmonary functional capacity in the exercise group. In addition, the controlled attenuation parameter analysis showed no significant decrease of hepatic steatosis in the exercise group. With regard to the systemic inflammation, there were, however, no significant differences in the cytokines between the groups.
CONCLUSIONS: An aerobic physical activity program of 24 weeks in NAFLD postmenopausal women showed improvement in some variables such as waist circumference, high-density lipoprotein cholesterol, and cardiopulmonary performance that may be beneficial in improving cardiovascular risk factors in this population.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27458060     DOI: 10.1097/GME.0000000000000647

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  11 in total

Review 1.  Exercising the hepatobiliary-gut axis. The impact of physical activity performance.

Authors:  Emilio Molina-Molina; Raquel Lunardi Baccetto; David Q-H Wang; Ornella de Bari; Marcin Krawczyk; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2018-06-14       Impact factor: 4.686

2.  Effect of silibinin capsules combined with lifestyle modification on hepatic steatosis in patients with chronic hepatitis B.

Authors:  Duo-Duo Lv; You-Juan Wang; Meng-Lan Wang; En-Qiang Chen; Ya-Chao Tao; Dong-Mei Zhang; Hong Tang
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 3.  NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.

Authors:  Stefano Ballestri; Fabio Nascimbeni; Enrica Baldelli; Alessandra Marrazzo; Dante Romagnoli; Amedeo Lonardo
Journal:  Adv Ther       Date:  2017-05-19       Impact factor: 3.845

4.  Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: A randomized controlled trial.

Authors:  Sulin Cheng; Jun Ge; Can Zhao; Shenglong Le; Yifan Yang; Dandan Ke; Na Wu; Xiao Tan; Xiaobo Zhang; Xiaming Du; Jianqin Sun; Renwei Wang; Yongyong Shi; Ronald J H Borra; Riitta Parkkola; Petri Wiklund; Dajiang Lu
Journal:  Sci Rep       Date:  2017-11-21       Impact factor: 4.379

5.  Lifestyle changes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.

Authors:  Tiziana Fernández; Macarena Viñuela; Catalina Vidal; Francisco Barrera
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

6.  Effect of Exercise Training on Serum Transaminases in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.

Authors:  Feng Hong; Yubo Liu; Veeranjaneya Reddy Lebaka; Arifullah Mohammed; Weibing Ye; Biqing Chen; Mallikarjuna Korivi
Journal:  Front Physiol       Date:  2022-06-28       Impact factor: 4.755

7.  Lifestyle modifications for nonalcohol-related fatty liver disease: a network meta-analysis.

Authors:  Elena Buzzetti; Audrey Linden; Lawrence Mj Best; Angela M Madden; Danielle Roberts; Thomas J G Chase; Suzanne C Freeman; Nicola J Cooper; Alex J Sutton; Dominic Fritche; Elisabeth Jane Milne; Kathy Wright; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-06-11

Review 8.  Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms.

Authors:  Hirokazu Takahashi; Kazuhiko Kotani; Kenichi Tanaka; Yuichiro Egucih; Keizo Anzai
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-15       Impact factor: 5.555

9.  Genistein and exercise modulated lipid peroxidation and improved steatohepatitis in ovariectomized rats.

Authors:  Namthip Witayavanitkul; Duangporn Werawatganon; Maneerat Chayanupatkul; Naruemon Klaikeaw; Sompol Sanguanrungsirikul; Prasong Siriviriyakul
Journal:  BMC Complement Med Ther       Date:  2020-06-01

Review 10.  Effect of Different Exercise Methods on Non-Alcoholic Fatty Liver Disease: A Meta-Analysis and Meta-Regression.

Authors:  Yingzhe Xiong; Qingwen Peng; Chunmei Cao; Zujie Xu; Bing Zhang
Journal:  Int J Environ Res Public Health       Date:  2021-03-21       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.